IGKV1D-22 and neoplasm: Chronic inflammation plays a crucial role, as pro-inflammatory mediators—such as S100A8/A9, tumor necrosis factor-α (TNF-α), and the TLR4-NF-κB signaling pathway—recruit myeloid cells and activate the endothelium, facilitating tumor extravasation (38).